Please login to the form below

Not currently logged in
Email:
Password:

Fampyra

This page shows the latest Fampyra news and features for those working in and with pharma, biotech and healthcare.

NICE denies two drugs in new MS guidance

NICE denies two drugs in new MS guidance

NICE denies two drugs in new MS guidance. Sativex and Fampyra too costly for NHS in England. ... Michelle Mitchell, chief executive of the MS Society, said: “ NICE's decision to reject Sativex and Fampyra as treatment options is really disappointing.

Latest news

  • FDA approves Biogen Idec's long-acting MS therapy FDA approves Biogen Idec's long-acting MS therapy

    Plegridy is Biogen Idec's fifth MS treatment to reach the market joining Avonex, Tysabri (natalizumab), fast-growing oral therapy Tecfidera (dimethyl fumarate) and Fampyra (fampridine).

  • IQWiG backs BMS' Yervoy for melanoma IQWiG backs BMS' Yervoy for melanoma

    delivered a negative appraisal for Biogen Idec's multiple sclerosis drug Fampyra (prolonged-release fampridine).

  • IQWiG turns down GSK’s lupus drug Benlysta IQWiG turns down GSK’s lupus drug Benlysta

    IQWiG turns down GSK’ s lupus drug Benlysta. German HTA body also declines to back Biogen Idec’ s Fampyra in its draft assessments. ... Further no from IGWiG for Biogen Idec's Fampyra. In addition to its Benlysta guidance, IQWiG also released a draft

  • Avonex slowdown hits Biogen Idec in first quarter Avonex slowdown hits Biogen Idec in first quarter

    Fampyra  (prolonged-release fampridine) for improving walking ability in MS patients made a solid start with $15m in revenues in the quarter following launches in Germany, the UK, Australia, Denmark, Norway,

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics